| Active Ingredient | Erlotinib Hydrochloride |
| Brand | Erolone |
| Country of origin | India |
| Form | Oral Tablet |
Erolone Tablet belongs to a drug class called tyrosine kinase inhibitors used to treat cancer. It contains the active ingredient Erlotinib Hydrochloride. It was first approved by the US Food and Drug Administration (FDA) in the year 2004.
Clinical Uses
The following are the uses of Erolone Tablet:
- EGFR-positive (Epidermal Growth Factor Receptor) non-small cell lung cancer
- Advanced pancreatic cancer
Dosage Options
Erolone Tablet is available in the following dose strengths: 100 mg and 150 mg. The dose will be decided by the doctor depending on the type and severity of the condition.
How It Works
Erolone Tablet is a targeted cancer medication that works by inhibiting the kinase activity of a protein called epidermal growth factor receptor (EGFR), which is essential for cell growth and survival. By blocking this, the medication stops the cancer from growing, dividing, and spreading.
Side Effects
Side effects of Erolone Tablet include:
- Diarrhea
- Rash
- Nausea
- Loss of appetite
- Difficult breathing
- Weakness
- Cough
- Fatigue
Consult your doctor if you experience any discomfort after ingestion of the medication to manage the symptom.
Precautions & Warnings
- Inform your doctor if you have a history of liver or kidney disease.
- Erolone Tablet is not safe during pregnancy. It can harm the unborn baby. Inform your doctor if you are pregnant or planning to become pregnant.
- Avoid smoking while taking Erolone Tablet. Dose adjustment may be needed if you smoke while taking Erolone Tablet.
- Avoid sun exposure while taking this medication, as it can cause a rash and worsen it if you get exposed to sunlight.
- Breastfeeding women should avoid taking Erolone Tablet.
Drug Interactions
Enrolone can interact with certain medications. Inform your doctor about any other medicines you are taking.
Some of the medicines that interact with Erolone Tablet include:
- Phenytoin
- Rifampin
- St. John’s Wort
- Nezatidine
- Carbamazepine
- Famotidine
- Ranitidine
- Omeprazole
Disclaimer
At 5M Biotech India we provide accurate, reliable and expert reviewed information. However, all our content on this platform is intended for informational purposes only and is not professional medical advice, diagnosis or treatment. While we make efforts to maintain accuracy, the information may contain mistakes, omissions or may not reflect the latest developments. Always consult your doctor regarding any medical concerns.
All medicine names, trademarks, and registered trademarks displayed on 5M Biotech India are property of their respective owners. 5M Biotech India and its operator are not affiliated with, endorsed by or authorized by any such trademark owners unless stated expressly. Any reference to trademarks or product names is made for informational purposes. No sponsorship, commercial relationship, approval or association with any trademark owner should be inferred. Information provided herein does not constitute advertising, promotion or an offer for sale of any medicinal goods and is intended solely for general informational purposes.
All trademarks, trade names, and brand names displayed on this website are used strictly in accordance with the applicable provisions of the Trade Marks Act, 1999, including Sections 30 and 30(1) relating to permitted and fair use. The respective trademark ownership has been duly and accurately identified under the “Manufacturer/TM Owner” section in compliance with applicable statutory requirements.
